X
30Jun

Healthcare M&A prospers, despite fall in deal activity

The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis - Although pharma, medical and biotech (PMB) M&A deal value for Q1 2020 came in at US$39.3 billion, 78% below the year before, this was primarily due to the outsized US$87.8 billion deal between Bristol-Myers Squibb and Celgene in early 2019....
By: White & Case LLP
Source Url: https://www.jdsupra.com/legalnews/healthcare-m-a-prospers-despite-fall-in-84295/

Related

CFIUS Proposes Filing Fees for Transaction Reviews

The U.S. Department of the Treasury late yesterday released a draft set of regulations that would es...

Read More >

U.S. Department of Labor Issues New Rule Clarifying Exclusions from Overtime Calculation

On December 12, 2019, the U.S. Department of Labor (“DOL”) finalized a new rule that lets employer...

Read More >

So much to do and so little time

Parliament will have a busy few months ahead. However, to the extent parliamentary time allows, Ther...

Read More >

Proskauer Scores Two Summary Judgments for Client Cedars-Sinai Medical Center Within 48 Hours

We’re delighted to report that we secured two summary judgments in two separate alleged discriminat...

Read More >

California Supreme Court Limits Recovery for PAGA Claims

Are you familiar with PAGA? Do you have a PAGA claim for unpaid wages filed against you right now? I...

Read More >

Board Revisits Recusal Rules

The National Labor Relations Board has issued its “Ethics Recusal Report,” which announces several...

Read More >